Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ThermoGenesis' stem cell harvester :

This article was originally published in Clinica

Executive Summary

Canadian regulators have given ThermoGenesis the all-clear to sell its automated system for harvesting stem cells from cord blood. The AutoXpress (AXP) device, which automates what was typically an 18-step manual process, harvests the cells in a functionally-closed processing set without requiring expensive clean rooms and labour intensive processes, said the Rancho Cordova, California firm. It also improves the recovery rates of the stem cells. The product will be marketed by its exclusive distributor, GE Healthcare.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT050899

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel